Showing results 1 to 20 of 21
next >
| Issue Date | Title | Author(s) |
| 2023-05 | The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review | Bhat, AA; Thapa, R; Afzal, O; Agrawal, N; Almalki, WH; Kazmi, I; Alzarea, SI; Altamimi, ASA; Prasher, P; Singh, SK; Dua, K; Gupta, G |
| 2023-04 | Galangin as an inflammatory response modulator: An updated overview and therapeutic potential | Thapa, R; Afzal, O; Alfawaz Altamimi, AS; Goyal, A; Almalki, WH; Alzarea, SI; Kazmi, I; Jakhmola, V; Singh, SK; Dua, K; Gilhotra, R; Gupta, G |
| 2023-03-09 | Sodium alginate-based drug delivery for diabetes management: A review. | Shaikh, MAJ; Gupta, G; Goyal, A; Gupta, MM; Afzal, O; Altamimi, ASA; Alzarea, SI; Almalki, WH; Kazmi, I; Negi, P; Singh, SK; Dua, K |
| 2023-02 | Chitosan-based nano drug delivery system for lung cancer | Kazmi, I; Shaikh, MAJ; Afzal, O; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Al-Abbasi, FA; Pandey, M; Dureja, H; Singh, SK; Dua, K; Gupta, G |
| 2023-01 | Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease | Purohit, M; Gupta, G; Afzal, O; Altamimi, ASA; Alzarea, SI; Kazmi, I; Almalki, WH; Gulati, M; Kaur, IP; Singh, SK; Dua, K |
| 2022-12-13 | Polysaccharide-Based Nanomedicines Targeting Lung Cancer | Bhat, AA; Gupta, G; Alharbi, KS; Afzal, O; Altamimi, ASA; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Chellappan, DK; Singh, SK; MacLoughlin, R; Oliver, BG; Dua, K |
| 2022-12 | Neuropharmacological effect of risperidone: From chemistry to medicine | Bhat, AA; Gupta, G; Afzal, O; Kazmi, I; Al-Abbasi, FA; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Singh, SK; Dua, K |
| 2022-11-22 | Role of flavonoids in management of various biological targets in Alzheimer's Disease: evidence from preclinical to clinical studies. | Alharbi, KS; Javed Shaikh, MA; Imam, SS; Alshehri, S; Ghoneim, MM; Almalki, WH; Singh, SK; Kumar, D; Kumar, AP; Dua, K; Chellappan, DK; Paudel, KR; Gupta, G |
| 2022-08 | An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy | Alharbi, KS; Javed Shaikh, MA; Afzal, O; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Singh, SK; Dua, K; Gupta, G |
| 2022-06-01 | Sodium alginate based drug delivery in management of breast cancer | Shaikh, MAJ; Alharbi, KS; Almalki, WH; Imam, SS; Albratty, M; Meraya, AM; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Altamimi, ASA; Singh, Y; Singh, SK; Dua, K; Gupta, G |
| 2022-06 | A narrative review on the biology of piezo1 with platelet-rich plasma in cardiac cell regeneration | Alharbi, KS; Almalki, WH; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Alfawaz Altamimi, AS; Singh, SK; Dua, K; Kumar, G |
| 2022-02-25 | Synergism of CD28 Immune Molecule in Late Immunosuppressive Phase of COVID-19: Effectiveness in Vaccinated Individuals. | Alharbi, KS; Singh, Y; Prasad Agrawal, G; Altowayan, WM; Almalki, WH; Sharma, A; Singh, SK; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-01-03 | CURRENT UPDATE ON THE PROTECTIVE EFFECT OF NARINGIN IN INFLAMMATORY LUNG DISEASES | Gupta, G; Almalki, WH; Kazmi, I; Fuloria, NK; Fuloria, S; Subramaniyan, V; Sekar, M; Singh, SK; Chellappan, DK; Dua, K |
| 2022-01-01 | Exploring the mechanistic perspective of a new anti-tumor agent: Melatonin | Rohilla, S; Singh, M; Priya, S; Almalki, WH; Haniffa, SM; Subramaniyan, V; Fuloria, S; Fuloria, NK; Sekar, M; Singh, SK; Jha, NK; Chellappan, DK; Negi, P; Dua, K; Gupta, G |
| 2022 | Current update on the protective effect of epicatechin in neurodegenerative diseases. | Thapa, R; Gupta, G; Dave, P; Singh, SK; Raizaday, A; Almalki, WH; Vyas, G; Singh, SK; Dua, K; Singh, Y |
| 2022 | PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer. | Alharbi, KS; Shaikh, MAJ; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Imam, SS; Alshehri, S; Ghoneim, MM; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| - | The therapeutic role of nutraceuticals targeting the Nrf2/ <scp>HO</scp> ‐1 signaling pathway in liver cancer | Alharbi, KS; Almalki, WH; Albratty, M; Meraya, AM; Najmi, A; Vyas, G; Singh, SK; Dua, K; Gupta, G |
| - | Role of Medicinal plant‐derived Nutraceuticals as a potential target for the treatment of breast cancer | Alharbi, KS; Almalki, WH; Makeen, HA; Albratty, M; Meraya, AM; Nagraik, R; Sharma, A; Kumar, D; Chellappan, DK; Singh, SK; Dua, K; Gupta, G |
| - | Bioanalytical Method Development, Validation and Stability Assessment of Xanthohumol in Rat Plasma | Harish, V; Almalki, WH; Alshehri, A; Alzahrani, A; Alzarea, SI; Kazmi, I; Gulati, M; Tewari, D; Chellappan, DK; Gupta, G; Dua, K; Singh, SK |
